🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Obesity or Overweight

Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity NCT07657676Phase 41 site📍 Beijing China National Center for Cardiovascular Diseases · Tests: Mazdutide, Placebo Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery NCT04136717NA1 site📍 Québec François Lellouche · Tests: Washout period, NIV - FreeO2, Nasal High flow Oxygen therapy - FreeO2, CPAP - Oxygen constant flow, CPAP - FreeO2 A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1) NCT07823608Phase 36 sites📍 Cullman📍 Riverside📍 Bradenton Pfizer · Tests: Berobenatide, Placebo A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus NCT07784725Phase 3212 sites📍 Dothan📍 Huntsville📍 Mesa AstraZeneca · Tests: AZD6234, Placebo A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus NCT07776509Phase 396 sites📍 Escondido📍 Lincoln📍 Walnut Creek AstraZeneca · Tests: Lenbelintide, Placebo CHOICE to AVOID or RESIST NCT06521021NA1 site📍 Beverly Hills Cedars-Sinai Medical Center · Tests: AVOID, RESIST NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks NCT05674799NA1 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: NDPP-NextGen Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) NCT07654361Phase 371 sites📍 Birmingham📍 Birmingham📍 Phoenix Gasherbrum Bio, Inc., a wholly owned subsidiary of Structur… · Tests: Aleniglipron, Placebo A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity NCT07665879Phase 12 sites📍 Neuss📍 Mölndal Eli Lilly and Company · Tests: Eloralintide, Placebo A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity. NCT07511205Phase 13 sites📍 Glendale📍 Brooklyn📍 Harrow AstraZeneca · Tests: AZD1043, Placebo A Study to Evaluate MWN109 Injection in Healthy Subjects NCT06859853Phase 11 site📍 Melbourne Shanghai Minwei Biotechnology Co., Ltd · Tests: Placebo, Subcutaneous single and mutiple dose Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects NCT07150975Phase 31 site📍 Beijing Gan & Lee Pharmaceuticals. · Tests: GZR18, Semaglutide(Wegovy® ) Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects NCT07150962Phase 11 site📍 Hefei Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS-9531 Tablet A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity NCT07567001Phase 3838 sites📍 Alexander City📍 Birmingham📍 Fairhope Novo Nordisk A/S · Tests: NNC0487-0111, Placebo Uterine Preservation Via Lifestyle Transformation NCT05903131Phase 23 sites📍 St Louis📍 Albuquerque📍 Oklahoma City Washington University School of Medicine · Tests: Telemedicine behavioral weight intervention, Progestin, Enhanced usual care, Levonorgestrel-releasing IUD. A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) NCT07654374Phase 374 sites📍 Birmingham📍 Chandler📍 Phoenix Gasherbrum Bio, Inc., a wholly owned subsidiary of Structur… · Tests: aleniglipron, aleniglipron, aleniglipron, Placebo Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity NCT07037459Phase 3657 sites📍 Birmingham📍 Dothan📍 Fairhope Amgen · Tests: Maridebart cafraglutide, Placebo FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing) NCT06724406NA1 site📍 Chapel Hill University of North Carolina, Chapel Hill · Tests: Family Skills Training Session Quantity: 5, Family Skills Training Session Mode: In-person, Family Skills Training Cont… AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea NCT07571005Phase 380 sites📍 San Diego📍 Miami📍 Naples Novo Nordisk A/S · Tests: NNC0487-0111, Placebo (matched to NNC0487-0111) Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight NCT07770841Phase 362 sites📍 Birmingham📍 Escondido📍 Huntington Park Novo Nordisk A/S · Tests: Semaglutide, Placebo A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM NCT07667803Phase 3325 sites📍 Birmingham📍 Dothan📍 Chandler AstraZeneca · Tests: Elecoglipron, Placebo A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight NCT07589608Phase 240 sites📍 Chandler📍 Scottsdale📍 Tucson Eli Lilly and Company · Tests: Macupatide, Eloralintide, Placebo Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology NCT07136844NA1 site📍 Liège Centre Hospitalier Universitaire de Liege · Tests: Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT), The 10-meter test (10MWT), The 4 sta… AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain NCT07509307Phase 381 sites📍 Escondido📍 Lancaster📍 Palm Springs Novo Nordisk A/S · Tests: NNC0487-0111, Placebo (matched to NNC0487-0111) Holbæk Obesity Treatment (HOT) Versus Conventional Obesity Treatment (COT) in Children With Overweight or Obesity. NCT05038683NA5 sites📍 Ballerup Municipality📍 Frederikssund📍 Nykøbing Falster Holbaek Sygehus · Tests: Holbæk Obesity Treatment, Conventional Obesity Treatment A Study of IBI3046 in Participants With Overweight or Obesity NCT07809945Phase 11 site📍 Beijing Innovent Biologics (Suzhou) Co. Ltd. · Tests: IBI3046, placebo A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity NCT06842186Phase 1, Phase 27 sites📍 Phoenix📍 Baltimore📍 Chisinau Wave Life Sciences USA, Inc. · Tests: WVE-007 Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity NCT07528027Phase 32 sites📍 Beijing📍 Harbin Shandong Suncadia Medicine Co., Ltd. · Tests: HRS-7535, Placebo A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity NCT07768813Phase 11 site📍 Mannheim Boehringer Ingelheim · Tests: Survodutide formulation A, Survodutide formulation B2 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight NCT07893093Phase 12 sites📍 San Antonio📍 Salt Lake City Ascletis Pharma (China) Co., Limited · Tests: ASC36 Injection A, for subcutaneous use, ASC36 Placebo Injection A, for subcutaneous use, ASC36 Injection B, for subcut…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy